SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-015763
Filing Date
2024-06-06
Accepted
2024-06-06 16:26:51
Documents
1
Period of Report
2024-06-04

Document Format Files

Seq Description Document Type Size
1 form4-06062024_080647.html 4  
1 form4-06062024_080647.xml 4 6333
  Complete submission text file 0001415889-24-015763.txt   7862
Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Issuer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SERESTHERAPEUTICS, INC. 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
von Moltke Lisa (Reporting) CIK: 0001808592 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36279 | Film No.: 241025846